Negocie Amgen AMGN

Venda
 Comprar

Gráfico Amgen ao vivo

5m 15m 30m 1h 4h 1d 1w

Fundamentos do instrumento

Weekly Search
Weekly
Daily
Data Fechar Mudança Alteração (%): Abertura Max Min

Amgen news

Frances Wang 2024 Nov 26, 16:00

Stock Market Today: S&P 500 and Dow Reach New High On Trump’s Tariff Policy

Stocks
Frances Wang 2024 Aug 04, 16:00

The Week Ahead: ISM services, SMCI

CFD Trading
Australian dollar shrugs at RBA decision to keep interest rates unchanged
Georgy Istigechev 2024 Aug 03, 21:00

Week ahead: RBA meeting, Uber earnings, and PMIs

CFD Trading Forex
Disney is catching up with Netflix
Neil Wilson 2024 Feb 01, 08:03

Week ahead: Earnings season climax

Forex Indices
Bank of England BoE
Neil Wilson 2023 Oct 27, 10:00

Week ahead: Fed, Bank of England seen on pause; Apple earnings

Forex Indices

Últimas notícias

Mostrar mais
Frances Wang 2025 Jul 27, 16:00

Trending Stocks Today: PLTR Stock , MCVT Stock, SMCI Stock, NVDA Stock

Stocks
Interest rate cut percentage
Tommy Yap 2025 Jul 26, 21:00

Week Ahead: Interest Rate Decisions from Fed, BoC, and BoJ in Focus

Forex Indices
Liam James 2025 Jul 25, 10:20

ECB Rate Cut Expectations Revised Amid Economic Resilience

Ava Grace 2025 Jul 25, 09:20

Hedge Funds Advise Buying Protection Against Potential Stock Market Downturn

Liam James 2025 Jul 25, 08:20

Federal Funds Rate vs. SOFR: Liquidity Measurement Debate in US Financial System

Ava Grace 2025 Jul 25, 07:20

Musk Praises Tesla Autopilot Performance in China Test, Sparking Debate

Emma Rose 2025 Jul 25, 06:20

Europe Offers Iran Extension on Sanctions Deadline Amid Nuclear Program Concerns

Noah Lee 2025 Jul 25, 05:20

BOJ Rate Hike Outlook: US Trade Deal Creates Space, But Challenges Remain

Info

Spread

1.91

Spread (%)

0.6361 %

Alavancagem

1:10

Juro overnight, Compra

-0.0597 %

Juro overnight, Venda

-0.0292 %

Moeda

USD

Horários de Negociação

Mercados fechados

Terça-feira

13:31 - 19:59

Segunda-feira

13:31-19:59

Quarta-feira

13:31-19:59

Quinta-feira

13:31-19:59

Sexta-feira

13:31-19:59

Análise e estatística

Abertura

---

Fechamento anterior

---

Alta/baixa em 52 semanas

--- – ---

Capitalização de mercado

164849893376

Ações em circulação

537705984

Data dos rendimentos (Próxima)

1999-11-22

Rendim Divid

2025-06-06

Data Ex-Dividendos

2025-05-16

Taxa anual futura de dividendos

9.52

Rendimento anual futuro de dividendos

0.0311

EPS

10.98

Saiba mais sobre este instrumento

Amgen Amgen Inc
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Instrumentos relacionados

Ativo
Venda
Comprar
Alteração (%):

Negociar agora

Negociar agora

Negociar agora

Negociar agora
Instrumentos relacionados

latest_education_articles

Mostrar mais
Trustpilot